Skip to content
BioVac
-
Africa CDC backs US$180M Biovac deal to end vaccine import dependence
The financing consortium includes Proparco, the European Investment Bank through the Human Development Accelerator initiative, and the International Finance Corporation.
-
Biovac secures USD108M for Africa’s first integrated vaccine manufacturing hub
Biovac will construct the new facility at its Cape Town manufacturing site, with completion expected by 2028.